Table: Kaken Pharmaceutical -Q1 group results

KAKEN PHARMACEUTICAL

04/08/2023 05:30

Aug 4 (Reuters)- 
             Kaken Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             18.15               18.20            73.10    
                 (-0.3 pct)          (-1.4 pct)       (+0.2 pct)  
  Operating          3.29                4.06             7.60    
                 (-18.8 pct)         (-8.3 pct)       (-5.0 pct)  
  Recurring          3.49                4.33             8.00    
                 (-19.5 pct)         (-7.0 pct)       (-8.3 pct)  
  Net                2.51                2.91             6.70    
                 (-13.7 pct)         (-13.5 pct)      (+23.2 pct) 
  EPS             66.99 yen           76.91 yen       178.80 yen  
  Ann Div                            150.00 yen       150.00 yen  
  -Q2 div                             75.00 yen        75.00 yen  
  -Q4 div                             75.00 yen        75.00 yen  
  
  NOTE - Kaken Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T